STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings
 

About: Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Employees: 16

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™